alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 4.1


 


Incorporated Under the Laws of the State of
Delaware on December 22, 2009


 


CANCER PREVENTION
PHARMACEUTICALS, INC.


 


Common Stock


 


This
Certifies That __________ is the record holder of ___________ Shares of the Common Stock of
CANCER PREVENTION PHARMACEUTICALS, INC., a Delaware corporation, hereinafter designated
the “Corporation,” transferable only on the books of the Corporation by the holder hereof, in person or by duly authorized
attorney, upon surrender of this Certificate properly endorsed or assigned.


 


A statement of the rights, preferences, privileges
and restrictions granted to or imposed upon the respective classes or series of shares of stock of the Corporation and upon holders
thereof as established by the Certificate of Incorporation or by any Certificate of Designation of Preferences, and the number
of shares constituting each series and the designations thereof, may be obtained by any stockholder upon request and without charge
at the principal office of the Corporation.


 


In
Witness Whereof, the Corporation has caused this Certificate to be signed by its duly authorized officers this
___ day of _____, ____.


 


	 	 	 	 
	 	Secretary	 	President
[Federal Register Volume 75, Number 83 (Friday, April 30, 2010)]
[Notices]
[Page 22805]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-10071]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

GENERAL SERVICES ADMINISTRATION

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

 [OMB Control No. 9000-0169; Docket 2010-0083; Sequence 21]


Submission for OMB Review; American Recovery and Reinvestment 
Act--Quarterly Reporting for Prime Contractors

AGENCIES:  Department of Defense (DoD), General Services Administration 
(GSA), and National Aeronautics and Space Administration (NASA).

ACTION: Withdrawal of Notice.

-----------------------------------------------------------------------

SUMMARY: The notice, OMB Control No. 9000-0169, American Recovery and 
Reinvestment Act--Quarterly Reporting for Prime Contractors published 
in the Federal Register is being withdrawn and no longer is accepting 
comments.

DATES: April 30, 2010

FOR FURTHER INFORMATION CONTACT: Mr. Ernest Woodson, Procurement 
Analyst, Contract Policy Branch, at telephone (202) 501-3775 or via e-
mail to <a href="/cdn-cgi/l/email-protection#781d0a161d0b0c560f17171c0b1716381f0b19561f170e"><span class="__cf_email__" data-cfemail="e580978b809691cb928a8a81968a8ba5829684cb828a93">[email protected]</span></a>. Please cite OMB Control No. 9000-0169, 
withdrawal.

SUPPLEMENTARY INFORMATION:

A. Background

    The Notice, published in the Federal Register at 75 FR 17919, on 
April 8, 2010, requesting comments regarding an extension to an 
existing OMB clearance (9000-0169) is being withdrawn. The notice is 
being withdrawn because it is associated with a second interim rule 
which is still in process, and has not been published. Comments are no 
longer being sought.

    Dated: April 26, 2010.
Al Matera,
Director, Acquisition Policy Division.
[FR Doc. 2010-10071 Filed 4-29-10; 8:45 am]
BILLING CODE 6820-EP-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     This schedule contains summary financial information extracted from the
     Company's consolidated balance sheet and consolidated statement of
     operations and is qualified in its entirety by reference to such
     consolidated financial statements together with the related footnotes
     thereto.
</LEGEND>
<CIK>                         0001029500
<NAME>                        MAXXAM Group Holdings Inc.
<MULTIPLIER>                                   1,000
<CURRENCY>                                     U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                              Dec-31-1999
<PERIOD-START>                                 Jan-1-1999
<PERIOD-END>                                   Dec-31-1999
<EXCHANGE-RATE>                                1
<CASH>                                         189,800
<SECURITIES>                                   43,800
<RECEIVABLES>                                  20,000
<ALLOWANCES>                                   0
<INVENTORY>                                    44,600
<CURRENT-ASSETS>                               315,900
<PP&E>                                         194,100
<DEPRECIATION>                                 93,700
<TOTAL-ASSETS>                                 1,131,700
<CURRENT-LIABILITIES>                          72,600
<BONDS>                                        985,400
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       0
<OTHER-SE>                                     (34,900)
<TOTAL-LIABILITY-AND-EQUITY>                   1,131,700
<SALES>                                        187,800
<TOTAL-REVENUES>                               187,800
<CGS>                                          159,500
<TOTAL-COSTS>                                  159,500
<OTHER-EXPENSES>                               32,700
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             82,800
<INCOME-PRETAX>                                177,900
<INCOME-TAX>                                   77,900
<INCOME-CONTINUING>                            100,000
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   100,000
<EPS-BASIC>                                    0
<EPS-DILUTED>                                  0



</TABLE>
<PAGE>

                       CONSENT OF INDEPENDENT ACCOUNTANTS

We consent to the incorporation by reference in the registration statements on
Form S-3 (File No. 333-62261 and File No. 333-74199 and in post effective
amendment No. 2 on Form S-3 to the registration statement on Form SB-2 (File No.
333-20187) of Univec, Inc. and Subsidiary, of our report, dated May 19, 1999, on
our audit of the consolidated financial statements of Univec, Inc. and
Subsidiary as of December 31, 1998 and December 31, 1997, and for the two years
then ended, which report appears in the Annual Report of Univec, Inc. on Form
10-KSB for the year ended December 31, 1998.



                                                 s/ Most Horowitz & Company, LLP
                                                 -------------------------------
                                                    Most Horowitz & Company, LLP


New York, New York
May 19, 1999
Exhibit 32.1  CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  In connection with the quarterly report of Green Bikes Rental Corporation (the “Company”) on Form 10-Q for the period ended April 30, 2008 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacities and on the dates indicated below, hereby certifies, pursuant to 18 U.S.C.` Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:  (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.  /s/ Yulia Nesterchuk Name: Yulia Nesterchuk Title: President, Chief Executive Officer, and Treasurer   June 16, 2008   A signed original of this written statement required by Section 906 has been provided to Green Bikes Rental Corporation and will be retained by Green Bikes Rental Corporation. and furnished to the Securities and Exchange Commission or its staff upon request.
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1
<CURRENCY> U.S. DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               DEC-31-1996
<EXCHANGE-RATE>                                      1
<CASH>                                       1,174,369
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                     108,736,974
<DEPRECIATION>                              18,852,000
<TOTAL-ASSETS>                              92,619,587
<CURRENT-LIABILITIES>                                0
<BONDS>                                     82,710,293
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                     49,410
<COMMON>                                           700
<OTHER-SE>                                   5,033,438
<TOTAL-LIABILITY-AND-EQUITY>                 5,083,541
<SALES>                                              0
<TOTAL-REVENUES>                            13,452,126
<CGS>                                                0
<TOTAL-COSTS>                                6,102,478
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           6,277,388
<INCOME-PRETAX>                              1,072,260
<INCOME-TAX>                                    37,000
<INCOME-CONTINUING>                          1,035,260
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,035,260
<EPS-PRIMARY>                                    14.79
<EPS-DILUTED>                                     0.56
        

</TABLE>
[Federal Register Volume 75, Number 83 (Friday, April 30, 2010)]
[Notices]
[Pages 22816-22817]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-10090]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Healthcare Infection Control Practices Advisory Committee 
(HICPAC)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned 
committee:


[[Page 22817]]


    Time and Date: 3:30 p.m.-4:30 p.m., May 17, 2010.
    Place: Teleconference.
    Status: Open to the public. The toll free dial in number is 
(800) 369-2094 and the passcode is 3518331. Teleconference access is 
limited only by availability of telephone ports. Registration and 
teleconference logon information is also available at http://www.cdc.gov/hicpac/.
    Purpose: The Committee is charged with providing advice and 
guidance to the Secretary, Department of Health and Human Services; 
the Director, CDC; and the Director, National Center for Emerging 
and Zoonotic Infectious Diseases (NCEZID), regarding the practice of 
hospital infection control and strategies for surveillance, 
prevention, and control of healthcare-associated infections (e.g., 
nosocomial infections), antimicrobial resistance, and related events 
in settings where healthcare is provided, including hospitals, 
ambulatory and long-term care facilities, and home health agencies. 
The committee shall also advise CDC on periodic updating of existing 
guidelines, development of new guidelines, guideline evaluation, and 
other policy statements regarding prevention of healthcare-
associated infections and healthcare-related conditions.
    Matters To Be Discussed: The agenda will include a follow up 
discussion on the draft Guidelines for the Prevention of 
Intravascular Catheter-Related Infections.
    Agenda items are subject to change as priorities dictate.
    For More Information Contact: Michelle W. King, HICPAC, Division 
of Healthcare Quality Promotion, NCEZID, CDC, l600 Clifton Road, 
NE., Mailstop A-07, Atlanta, Georgia 30333, Telephone: (404) 639-
2936, E-mail: <a href="/cdn-cgi/l/email-protection#145c5d57445557547770773a737b62"><span class="__cf_email__" data-cfemail="763e3f352637353615121558111900">[email protected]</span></a>.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substance and 
Disease Registry.

    Dated: April 26, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2010-10090 Filed 4-29-10; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
EXHIBIT 32.1


CERTIFICATION OF


CHIEF EXECUTIVE OFFICER


PURSUANT TO 18 U.S.C. SECTION 1350




In connection with the accompanying Quarterly Report on Form 10-Q/A of Zhong Sen International Tea Companyfor the period ending November 20, 2010, I, Li Wang, Chief Executive Officer of Zhong Sen International Tea Company hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:




1.
Such Quarterly Report of Form 10-Q/A for the period ending November 30, 2010, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and2.
The information contained in such Quarterly Report on Form 10-Q/A for the period ended November 30, 2010, fairly represents in all material respects, the financial condition and results of operations of Zhong Sen International Tea Company.




Date:  May 23, 2011/s/ Li WangLi Wang

Chief Executive Officer
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service 

 National Institute for Occupational

 Safety and Health 

Robert A. Taft Laboratories

 4676 Columbia Parkway 

Cincinnati, OH 45226-1998 

Phone: 877-222-7570 

Fax: 513-533-6826 

March 7, 2012 

Ms. Rachel Leiton, Director 

Division of Energy Employees Occupational 

 Illness Compensation 

U.S. Department of Labor 

200 Constitution Avenue, N.W., Room C-3321 

Washington, District of Columbia 20210 

Subject: Addition of a class of employees from the Linde Ceramics Plant to the Special Exposure 

Cohort 

Dear Ms. Leiton: 

On behalf of the Secretary of the Department of Health and Human Services (HHS), and as required 

by 42 C.F.R. § 83.17(d), I am notifying you of the final effect of the HHS decision to designate a 

class of employees from the Linde Ceramics Plant in Tonawanda, NY, as an addition to the Special 

Exposure Cohort (SEC) under the Energy Employees Occupational Illness Compensation Program 

Act of 2000. On February 2, 2012, as provided for under 42 U.S.C. § 7384q(b), the Secretary of 

HHS designated the following class of employees as an addition to the SEC: 

All Atomic Weapons Employees who worked in any area at the Linde Ceramics Plant in 

Tonawanda, New York, from November 1, 1947, through December 31, 1953, for a number 

of work days aggregating at least 250 work days, occurring either solely under this 

employment or in combination with work days within the parameters established for one or 

more other classes of employees included in the SEC. 

This designation became effective on March 3, 2012, as provided for under 42 U.S.C. § 

7384l(14)(C). Hence, beginning on March 3, 2012, members of this class of employees, defined as 

reported in this notice, became members of the SEC. 

Sincerely, 

[Signature on file]

 Stuart L. Hinnefeld, Director 

 Division of Compensation Analysis and Support 

 National Institute for Occupational Safety and Health
##### 



EXHIBIT 21.1

SUBSIDIARIES  As of December 31, 2002



| |                                                                                                                  
| | -----------------------------------------------------------------------------------------------------------------
| | 1. Hillman Group Capital Trust (formerly SunSource Capital Trust)
Organized in the State of Delaware             
|
| | 2. Hillman Investment Company (formerly SunSource Investment Company,
Inc.) Incorporated in the State of Delaware
|
| | 3. The Hillman Group, Inc.
Incorporated in the State of Delaware                                                 



| |                                                                                                   
| | --------------------------------------------------------------------------------------------------
| | a. SunSource Technology Services, L.L.C.
Incorporated in the State of Delaware                    
|
| | b. SunSource Integrated Services
de Mexico S. A. DE C. V.
Incorporated in Ciudad de Mexico, Mexico
|
| | c. SunSub C, Inc.
Incorporated in the State of Delaware                                           



| |                                                              
| | -------------------------------------------------------------
| | i. SunSub Holdings L.L.C.
Incorporated in the State of Nevada



| |                                                                                  
| | ---------------------------------------------------------------------------------
| | d. The Hillman Group Canada, Ltd.
Incorporated in the Province of Ontario, Canada
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Government Printing Office

The Depository Library Council to the Public Printer (DLC) will meet on Monday, March 31, 2008, through Wednesday, April 2, 2008, at Westin Crown Center, located in Kansas City, MO. The sessions will take place from 8 a.m. to 5 p.m. Monday through Wednesday. The meeting will be held at the Westin Crown Center, One Pershing Road, Kansas City, MO.

The purpose of this meeting is to discuss the Federal Depository Library Program. All sessions are open to the public. The sleeping rooms available at the Westin Crown Center will be at the Government rate of $103.00 (plus applicable state and local taxes, currently 15.22%) a night for a single or double. The Westin Crown Center is in compliance with the requirements of Title III of the Americans with Disabilities Act and meets all Fire Safety Act regulations.

Robert C. Tapella,

Public Printer of the United States.

[FR Doc. 08-945 Filed 3-5-08; 8:45 am]

BILLING CODE 1520-01-M
Exhibit
32.2


CERTIFICATION
PURSUANT TO


18
U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002





In
connection with the Quarterly Report of Vida Life International, Ltd., a Nevada
corporation (“Company”), on Form 10-Q, for the period ending September 30, 2008,
as filed with the Securities and Exchange Commission on the date hereof
(“Report”), John C. Jordan, Chief Financial Officer of the Company, certifies to
the best of his knowledge, pursuant to 18 U.S.C. § 1350, as adopted
pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:





(1)
            The
      Report fully complies with the requirements of Section 13(a) or 15(d) of
      the Securities Exchange Act of 1934;
and





(2)
            The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and result of operations of the
      Company.





A signed
original of this written statement required by Section 906 has been provided to
Vida Life International, Ltd., and will be retained by Vida Life International,
Ltd. and furnished to the Securities and Exchange Commission or its staff upon
request.





Date:
      November 19, 2008
              By:
              /s/
      John C. JordanJohn
      C. JordanChief
      Financial Officer
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

# ACTION:

Announcement of meeting. 

# SUMMARY:

This notice announces the 22nd meeting of the American Health Information Community Chronic Care Workgroup in accordance with the Federal Advisory Committee Act (Pub. L. 92-463, 5 U.S.C., App.)

# DATES:

February 15, 2008, from 1 p.m. to 4 p.m., Eastern Time.

# ADDRESSES:

Mary C. Switzer Building (330 C Street, SW., Washington, DC 20201), Conference Room 4090. Please bring photo ID for entry to a Federal building.

# FOR FURTHER INFORMATION CONTACT:

*http://www.hhs.gov/​healthit/​ahic/​chroniccare/​.*

# SUPPLEMENTARY INFORMATION:

The workgroup will hear testimony on ways to use information technology to better coordinate care for patients with chronic conditions and will discuss this information in light of opportunities to better facilitate patient care coordination.

                    The meeting will be available via Web cast. For additional information, go to:                     *http://www.hhs.gov/​healthit/​ahic/​chroniccare/​cc_​instruct.html*

Dated: January 18, 2008.

Judith Sparrow,

Director, American Health Information Community, Office of Programs and Coordination, Office of the National Coordinator for Health Information Technology.

[FR Doc. 08-365  Filed 1-28-08; 8:45 am]

BILLING CODE 4150-45-M